Science
Johnson & Johnson says its COVID booster shot increases immunity
Johnson & Johnson said a booster shot of its COVID vaccine generates a "rapid and robust" spike in antibodies. Mark Strassmann shares more.
Science
More job listings have vaccine requirements
If you're looking for a job, you may need to get a jab first. CBS News' Elise Preston reports on the growing number of job listings that come with a vaccine mandate.
Johnson & Johnson booster study shows promising results
Johnson & Johnson says new research shows a second shot of its COVID vaccine boosts antibodies nine-fold. Meanwhile, the debate over mask and vaccine mandates is dividing Americans. CBS News national correspondent Mark Strassmann reports, then Dr. Amesh Adalja from Johns Hopkins University Bloomberg School of Public Health joins CBSN to discuss the latest research.
Climate change made catastrophic flood more likely, study finds
And there's one factor that could mean these findings underestimate the impact.
Caldor Fire prompts hundreds of animal rescues in California
Evacuation Team Amador, a group of 39 members and dozens of volunteers, has rescued 483 animals since the fire started on August 14.
FDA OK of Pfizer vaccine could bring more corporate mandates
Expect "a very quick domino effect of employers taking advantage of this," one labor attorney said.
U.S. health officials urge Americans to get vaccinated
Health officials are urging Americans to get vaccinated as most U.S. counties experience "high" coronavirus transmission. As CBS News' Manuel Bojorquez reports, Dr. Fauci says the nation could get control of the virus by next spring if more people roll up their sleeves. Then, Dr. Adam Brown, an emergency physician and the COVID national task force chair at Envision Healthcare, joins CBSN's Elaine Quijano to discuss the rest of the day's COVID headlines.
Officials hope FDA's Pfizer approval assures holdouts
The White House coronavirus response coordinator is urging businesses to implement vaccine requirements after the FDA gave full approval to Pfizer's COVID vaccine. This comes as tens of millions of Americans who are eligible to get a COVID shot haven't. Manuel Bojorquez reports.
U.S. report anticipated on coronavirus origins
A new report on the origins of the coronavirus could land in the hands of President Biden on Tuesday, but Beijing is working to blame the U.S. for the outbreak. CBS News Asia correspondent Ramy Inocencio joins CBSN AM with more details.
Impact of FDA approval for Pfizer's vaccine
Pfizer's COVID-19 vaccine has become the first in the U.S. to receive full approval from the FDA for people ages 16 and up. The vaccine still remains under emergency use authorization for children 12 to 15. Dr. Jessica Shepherd, chief medical officer at Verywell Health, joins CBSN AM with a look at what this means for adults, children and people who've hesitated to get the vaccine.
Live
Live Updates: Trump tells GOP "we gave this a very strong shot"
Supreme Court rejects Trump's request in California mail ballots dispute
U.S. strikes Iranian targets
Why Texas Dems are forecasting a "Hispanic hurricane" in midterms
Live
Trump says "Iran wants a settlement, as soon as possible"
Pilot in plane crash said "we're managing the ice," then "Mayday"
ICE planning to deport Afghans through Pakistan, official says
Case dismissed against 2 ex-FBI officials in Hunter Biden probe
First on CBS